New advice on vitamin D supplements

The latest advice from Public Health England (PHE) recommends that adults and children over the age of one should consider taking a daily supplement containing 10mcg of vitamin D, especially during autumn and winter. Those who are at a higher risk of vitamin D deficiency, such as people who have little or no exposure to the sun, those who cover their skin when outside, and people with dark skin from African, African-Caribbean, and South Asian backgrounds, are advised to take a supplement all year round. This advice is based on a review by the Scientific Advisory Committee on Nutrition (SACN), which identified these groups as being at risk of vitamin D deficiency.

Meningococcal Septicaemia and Other Skin Conditions

Meningococcal septicaemia is a serious condition that can cause a non-blanching purpuric eruption all over the body. This symptom is a key indicator of the disease and should be taken seriously. Other skin conditions, such as giant urticaria, measles rash, and haemophilia, do not typically present with this type of rash.

Giant urticaria is characterised by recurrent attacks of oedema that appear suddenly in various areas of the body. The measles rash, on the other hand, appears as a macular eruption on the face and neck that spreads over three days. Haemophilia is not associated with any generalised rash.

HSP, another skin condition, may present in a subacute manner and is not typically associated with a high fever in an acutely unwell child. It may occur following an upper respiratory tract infection.

Vision Testing for Children

A newborn’s visual acuity is not fully developed and only reaches about 6/200. However, it improves to 6/60 by the age of 3 months and reaches adult levels at around 2 years old. When assessing a child’s vision, there are several tests that may be performed. At birth, a red reflex test is typically done. At 6 weeks, the child is asked to fix and follow an object to 90 degrees, such as a red ball 90cm away. By 3 months, the child should be able to fix and follow an object to 180 degrees without any squinting. At 12 months, the child should be able to pick up small objects, such as ‘hundreds and thousands,’ with a pincer grip. For children over 3 years old, letter matching tests are commonly used, while Snellen charts are used for those over 4 years old. Additionally, Ishihara plates may be used to test for color vision. These tests are important in identifying any potential vision problems in children and ensuring they receive appropriate treatment.

Fluid intake should be limited for children from 1 hour before to 8 hours after administering desmopressin.

Managing Nocturnal Enuresis in Children

Nocturnal enuresis, also known as bedwetting, is a common condition in children. It is defined as the involuntary discharge of urine during sleep in children aged 5 years or older who have not yet achieved continence. There are two types of nocturnal enuresis: primary and secondary. Primary enuresis occurs when a child has never achieved continence, while secondary enuresis occurs when a child has been dry for at least 6 months before.

When managing nocturnal enuresis, it is important to look for possible underlying causes or triggers such as constipation, diabetes mellitus, or recent onset urinary tract infections. General advice includes monitoring fluid intake and encouraging regular toileting patterns, such as emptying the bladder before sleep. Lifting and waking techniques and reward systems, such as star charts, can also be effective.

The first-line treatment for nocturnal enuresis is an enuresis alarm, which has a high success rate. These alarms have sensor pads that detect wetness and wake the child up when they start to wet the bed. If an enuresis alarm is not effective or not acceptable to the family, desmopressin can be used for short-term control, such as for sleepovers. It is important to note that reward systems should be given for agreed behavior rather than dry nights, such as using the toilet to pass urine before sleep. By following these management strategies, children with nocturnal enuresis can achieve continence and improve their quality of life.

There is no need to exclude a child with slapped cheek disease from school or childcare setting as they are no longer contagious once the rash appears.

The Health Protection Agency has provided guidance on when children should be excluded from school due to infectious conditions. Some conditions, such as conjunctivitis, fifth disease, roseola, infectious mononucleosis, head lice, threadworms, and hand, foot and mouth, do not require exclusion. Scarlet fever requires exclusion for 24 hours after commencing antibiotics, while whooping cough requires exclusion for 2 days after commencing antibiotics or 21 days from onset of symptoms if no antibiotics are taken. Measles requires exclusion for 4 days from onset of rash, rubella for 5 days from onset of rash, and Chickenpox until all lesions are crusted over. Mumps requires exclusion for 5 days from onset of swollen glands, while diarrhoea and vomiting require exclusion until symptoms have settled for 48 hours. Impetigo requires exclusion until lesions are crusted and healed, or for 48 hours after commencing antibiotic treatment, and scabies requires exclusion until treated. influenza requires exclusion until the child has recovered for 48 hours.

Regarding Chickenpox, Public Health England recommends that children should be excluded until all lesions are crusted over, while Clinical Knowledge Summaries suggest that infectivity continues until all lesions are dry and have crusted over, usually about 5 days after the onset of the rash. It is important to follow official guidance and consult with healthcare professionals if unsure about exclusion periods for infectious conditions.

If parents take their child to the A&E department instead of a GP on a regular basis, it could be an indication of child abuse. This is because they may assume that seeing a different doctor each time will decrease the likelihood of any suspicions being raised.

Recognizing Child Abuse: Signs and Symptoms

Child abuse is a serious issue that can have long-lasting effects on a child’s physical and emotional well-being. It is important to recognize the signs and symptoms of child abuse in order to protect vulnerable children. One way that abuse may come to light is through a child’s own disclosure. However, there are other factors that may indicate abuse, such as inconsistencies in a child’s story or repeated visits to emergency departments. Children who appear frightened or withdrawn may also be experiencing abuse, exhibiting a state of frozen watchfulness.

Physical signs of abuse can also be indicative of maltreatment. Bruising, fractures (especially in the metaphyseal area or posterior ribs), and burns or scalds are all possible signs of abuse. Additionally, a child who is failing to thrive or who has contracted a sexually transmitted infection may be experiencing abuse. It is important to be aware of these signs and to report any concerns to the appropriate authorities. By recognizing and addressing child abuse, we can help protect vulnerable children and promote their safety and well-being.

Croup is a respiratory infection that affects young children, typically those between 6 months and 3 years old. It is most common in the autumn and is caused by parainfluenza viruses. The main symptom is stridor, which is caused by swelling and secretions in the larynx. Other symptoms include a barking cough, fever, and cold-like symptoms. The severity of croup can be graded based on the child’s symptoms, with mild cases having occasional coughing and no audible stridor at rest, and severe cases having frequent coughing, prominent stridor, and significant distress or lethargy. Children with moderate or severe croup should be admitted to the hospital, especially if they are under 6 months old or have other airway abnormalities. Diagnosis is usually made based on clinical symptoms, but a chest x-ray can show subglottic narrowing. Treatment typically involves a single dose of oral dexamethasone or prednisolone, and emergency treatment may include high-flow oxygen or nebulized adrenaline. While dexamethasone is the preferred and commonly used treatment for croup, prednisolone is not typically recommended as a first-line treatment for croup in clinical guidelines. Dexamethasone is the standard corticosteroid used due to its efficacy and safety profile in managing croup symptoms.

Infant Weight Loss and Monitoring

It is normal for infants to experience weight loss during the early days of life. However, if an infant loses more than 10% of their birth weight, it is important to assess for dehydration, underlying illness, and feeding problems. Monitoring the infant closely is also recommended, but weighing should not be done more frequently than daily according to NICE guidelines. If there is evidence of illness or failure to respond to feeding support, referral to paediatric services should be considered.

Supplementation with infant formula may result in the cessation of breastfeeding, so it is advised to support the mother to continue breastfeeding. The RCGP recommends testing for normality and sometimes, monitoring or reassurance may be the answer to questions related to infant weight loss. By closely monitoring and addressing any concerns, infants can return to their birth weight by 3 weeks of age.

It is not recommended to prescribe oral choline salicylate gels to teething children as it may increase the risk of Reye’s syndrome. However, in this case, reassurance is appropriate as the child’s symptoms are mild and self-limiting. Simple measures such as allowing the child to bite on a cool, clean object and administering paracetamol/ibuprofen suspension for those aged three months and older can be helpful. It is not recommended to use topical anaesthetics or herbal teething powders as they may have adverse effects.

Teething: Symptoms, Diagnosis, and Treatment Options

Teething is the process of primary tooth eruption in infants, which typically begins around 6 months of age and is usually complete by 30 months of age. It is characterized by a subacute onset of symptoms, including gingival irritation, parent-reported irritability, and excessive drooling. These symptoms occur in approximately 70% of all children and are equally prevalent in boys and girls, although girls tend to develop their teeth sooner than boys.

During examination, teeth can typically be felt below the surface of the gums prior to breaking through, and gingival erythema will be noted around the site of early tooth eruption. Treatment options include chewable teething rings and simple analgesia with paracetamol or ibuprofen. However, topical analgesics or numbing agents are not recommended, and oral choline salicylate gels should not be prescribed due to the risk of Reye’s syndrome.

It is important to note that teething doesn’t cause systemic symptoms such as fevers or diarrhea, and these symptoms should be treated as warning signs of other systemic illness. Additionally, teething necklaces made from amber beads on a cord are a common naturopathic treatment for teething symptoms but represent a significant strangulation and choking hazard. Therefore, it is crucial to avoid their use.

In conclusion, teething is a clinical diagnosis that can be managed with simple interventions. However, it is essential to be aware of potential hazards and to seek medical attention if systemic symptoms are present.

Desmopressin is a viable option for managing enuresis in the short term, particularly in children aged 7 and above. However, its effectiveness in younger children is not well-established. It is advisable to commence treatment a week before a school trip to assess its efficacy. Simply limiting fluid intake is not recommended. Karim should be offered desmopressin as a treatment option, along with reassurance. Duloxetine is not suitable for this condition. While an enuresis alarm is a viable long-term solution, it is not practical to try it out during a school trip.

Managing Nocturnal Enuresis in Children

Nocturnal enuresis, also known as bedwetting, is a common condition in children. It is defined as the involuntary discharge of urine during sleep in children aged 5 years or older who have not yet achieved continence. There are two types of nocturnal enuresis: primary and secondary. Primary enuresis occurs when a child has never achieved continence, while secondary enuresis occurs when a child has been dry for at least 6 months before.

When managing nocturnal enuresis, it is important to look for possible underlying causes or triggers such as constipation, diabetes mellitus, or recent onset urinary tract infections. General advice includes monitoring fluid intake and encouraging regular toileting patterns, such as emptying the bladder before sleep. Lifting and waking techniques and reward systems, such as star charts, can also be effective.

The first-line treatment for nocturnal enuresis is an enuresis alarm, which has a high success rate. These alarms have sensor pads that detect wetness and wake the child up when they start to wet the bed. If an enuresis alarm is not effective or not acceptable to the family, desmopressin can be used for short-term control, such as for sleepovers. It is important to note that reward systems should be given for agreed behavior rather than dry nights, such as using the toilet to pass urine before sleep. By following these management strategies, children with nocturnal enuresis can achieve continence and improve their quality of life.

Trinucleotide repeat disorders are genetic conditions that occur due to an abnormal number of repeats of a repetitive sequence of three nucleotides. These expansions are unstable and may enlarge, leading to an earlier age of onset in successive generations, a phenomenon known as anticipation. In most cases, an increase in the severity of symptoms is also observed. It is important to note that these disorders are predominantly neurological in nature. Examples of such disorders include Fragile X, Huntington’s, myotonic dystrophy, Friedreich’s ataxia, spinocerebellar ataxia, spinobulbar muscular atrophy, and dentatorubral pallidoluysian atrophy. It is interesting to note that Friedreich’s ataxia is an exception to the rule and doesn’t demonstrate anticipation.

Child Protection and Sexual Offences

The Sexual Offences Act 2003 states that children under the age of 13 are not capable of giving consent to sexual activity. Any sexual offence involving a child under 13 should be treated with utmost seriousness. Health professionals should consider referring such cases to social services under the Child Protection Procedures. It is advisable to seek advice from designated child protection professionals in the first instance.

Developmental Milestones in Social Behaviour, Feeding, Dressing, and Play

Developmental milestones are important markers in a child’s growth and development. In terms of social behaviour and play, there are several milestones that parents and caregivers can look out for. At six weeks, a baby may start to smile, which develops into laughter by three months. At six months, they become less shy, but by nine months, they may exhibit shyness. Additionally, babies at this age tend to put everything in their mouths.

In terms of feeding, a six-month-old may start to put their hand on the bottle while being fed. By 12-15 months, they can drink from a cup and use a spoon, which develops over a three-month period. At two years, they become competent with a spoon and don’t spill with a cup, and by three years, they can use a spoon and fork. Finally, at five years, they can use a knife and fork.

When it comes to dressing, a child may start to help with getting dressed and undressed at 12-15 months. By 18 months, they can take off shoes and hats but may not be able to replace them. At two years, they can put on hats and shoes, and by four years, they can dress and undress independently, except for laces and buttons.

Lastly, in terms of play, a nine-month-old may start to play peek-a-boo and wave bye-bye. By 12 months, they may play pat-a-cake, and at 18 months, they can play contentedly alone. At two years, they may play near others but not necessarily with them, and by four years, they can play with other children. These milestones can help parents and caregivers track a child’s development and ensure they are meeting age-appropriate goals.

When breastfed infants display symptoms of gastro-oesophageal reflux, it is important for a qualified individual to conduct a breastfeeding assessment. Simply observing the infant without providing any treatment is not appropriate, as the reported distress of the infant must be taken into consideration. While a proton pump inhibitor is a viable treatment option, an alginate is preferred due to its lower risk of side effects, provided it is effective. Alginates can be administered to breastfed infants by mixing them with cooled boiled water or expressed breast milk.

Gastro-oesophageal reflux is a common cause of vomiting in infants, with around 40% of babies experiencing some degree of regurgitation. However, certain risk factors such as preterm delivery and neurological disorders can increase the likelihood of developing this condition. Symptoms typically appear before 8 weeks of age and include vomiting or regurgitation, milky vomits after feeds, and excessive crying during feeding. Diagnosis is usually made based on clinical observation.

Management of gastro-oesophageal reflux in infants involves advising parents on proper feeding positions, ensuring the infant is not overfed, and considering a trial of thickened formula or alginate therapy. However, proton pump inhibitors (PPIs) are not recommended as a first-line treatment for isolated symptoms of regurgitation. PPIs may be considered if the infant experiences unexplained feeding difficulties, distressed behavior, or faltering growth. Metoclopramide, a prokinetic agent, should only be used with specialist advice.

Complications of gastro-oesophageal reflux can include distress, failure to thrive, aspiration, frequent otitis media, and dental erosion in older children. If medical treatment is ineffective and severe complications arise, fundoplication may be considered. It is important for healthcare professionals to be aware of the risk factors, symptoms, and management options for gastro-oesophageal reflux in infants.

Hib Vaccine: Protection Against Invasive Haemophilus Disease

The Hib vaccine is a conjugated polysaccharide vaccine that is given in a course of three doses at monthly intervals to infants at two, three, and four months of age, along with other routine vaccinations. A single dose is effective for children over 13 months of age. However, it is only given after 10 years of age to those children who are at increased risk of invasive Haemophilus disease, such as those with sickle cell disease, undergoing antineoplastic therapy, or with an absent spleen. Although highly effective, vaccination failures have been reported.

Unlike influenza vaccines, hypersensitivity to egg is not a contraindication to Hib. However, evidence of a previous anaphylactic reaction contraindicates the use of the MMR and yellow fever vaccines. The Hib vaccine offers protection against the capsulated form of Hib that causes meningitis, acute epiglottitis, pneumonia, septic arthritis, and cellulitis. Overall, the Hib vaccine is an important tool in preventing invasive Haemophilus disease in children.

The vaccine regimen includes immunization against diphtheria, tetanus, pertussis, polio, Haemophilus influenza type b, and hepatitis B, as well as vaccination against pneumococcus, rotavirus, and meningococcus B.

The UK immunisation schedule recommends certain vaccines at different ages. At birth, the BCG vaccine is given if the baby is at risk of tuberculosis. At 2, 3, and 4 months, the ‘6-1 vaccine’ (diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B) and oral rotavirus vaccine are given, along with Men B and PCV at specific intervals. At 12-13 months, the Hib/Men C, MMR, PCV, and Men B vaccines are given. At 3-4 years, the ‘4-in-1 Preschool booster’ (diphtheria, tetanus, whooping cough and polio) and MMR vaccines are given. At 12-13 years, the HPV vaccination is given, and at 13-18 years, the ‘3-in-1 teenage booster’ (tetanus, diphtheria and polio) and Men ACWY vaccines are given. Additionally, the flu vaccine is recommended annually for children aged 2-8 years.

It is important to note that the meningitis ACWY vaccine has replaced meningitis C for 13-18 year-olds due to an increased incidence of meningitis W disease in recent years. The ACWY vaccine is also offered to new students up to the age of 25 years at university. GP practices will automatically send letters inviting 17-and 18-year-olds in school year 13 to have the Men ACWY vaccine, while students going to university or college for the first time should contact their GP to have the vaccine before the start of the academic year.

The Men C vaccine used to be given at 3 months but has now been discontinued as there are almost no cases of Men C disease in babies or young children in the UK. All children will continue to be offered the Hib/Men C vaccine at one year of age, and the Men ACWY vaccine at 14 years of age to provide protection across all age groups.

Managing Asthma in Children: NICE Guidelines

The National Institute for Health and Care Excellence (NICE) released guidelines in 2017 for the management of asthma in children aged 5-16. These guidelines follow a stepwise approach, with treatment options based on the severity of the child’s symptoms. For newly-diagnosed asthma, short-acting beta agonists (SABA) are recommended. If symptoms persist or worsen, a combination of SABA and paediatric low-dose inhaled corticosteroids (ICS) may be used. Leukotriene receptor antagonists (LTRA) and long-acting beta agonists (LABA) may also be added to the treatment plan.

For children under 5 years old, clinical judgement plays a greater role in diagnosis and treatment. The stepwise approach for this age group includes an 8-week trial of paediatric moderate-dose ICS for newly-diagnosed asthma or uncontrolled symptoms. If symptoms persist, a combination of SABA and paediatric low-dose ICS with LTRA may be used. If symptoms still persist, referral to a paediatric asthma specialist is recommended.

It is important to note that NICE doesn’t recommend changing treatment for patients with well-controlled asthma simply to adhere to the latest guidelines. Additionally, maintenance and reliever therapy (MART) may be used for combined ICS and LABA treatment, but only for LABAs with a fast-acting component. The definitions for low, moderate, and high-dose ICS have also changed, with different definitions for children and adults.

There is no need to exclude children with head lice from school, so the answer to the question is no. The mother should be comforted that her daughter can still attend school, and there is no reason for the patient to stay home. Therefore, the other answer options for this question are incorrect.

The Health Protection Agency has provided guidance on when children should be excluded from school due to infectious conditions. Some conditions, such as conjunctivitis, fifth disease, roseola, infectious mononucleosis, head lice, threadworms, and hand, foot and mouth, do not require exclusion. Scarlet fever requires exclusion for 24 hours after commencing antibiotics, while whooping cough requires exclusion for 2 days after commencing antibiotics or 21 days from onset of symptoms if no antibiotics are taken. Measles requires exclusion for 4 days from onset of rash, rubella for 5 days from onset of rash, and Chickenpox until all lesions are crusted over. Mumps requires exclusion for 5 days from onset of swollen glands, while diarrhoea and vomiting require exclusion until symptoms have settled for 48 hours. Impetigo requires exclusion until lesions are crusted and healed, or for 48 hours after commencing antibiotic treatment, and scabies requires exclusion until treated. influenza requires exclusion until the child has recovered for 48 hours.

Regarding Chickenpox, Public Health England recommends that children should be excluded until all lesions are crusted over, while Clinical Knowledge Summaries suggest that infectivity continues until all lesions are dry and have crusted over, usually about 5 days after the onset of the rash. It is important to follow official guidance and consult with healthcare professionals if unsure about exclusion periods for infectious conditions.

The vaccine for rotavirus is administered orally and is live attenuated. It is given to infants at two and three months of age, along with other oral vaccines like polio and typhoid. Two doses are necessary, and it is not typically given to children at three years of age. This vaccine is not injected and is not an inactivated toxin vaccine, which includes vaccines for tetanus, diphtheria, and pertussis.

The Rotavirus Vaccine: A Vital Tool in Preventing Childhood Mortality

Rotavirus is a significant public health concern, causing high rates of morbidity and hospitalization in developed countries and childhood mortality in developing nations. To combat this, a vaccine was introduced into the NHS immunization program in 2013. The vaccine is an oral, live attenuated vaccine that requires two doses, the first at two months and the second at three months. It is important to note that the first dose should not be given after 14 weeks and six days, and the second dose cannot be given after 23 weeks and six days due to the theoretical risk of intussusception.

The vaccine is highly effective, with an estimated efficacy rate of 85-90%, and is predicted to reduce hospitalization rates by 70%. Additionally, the vaccine provides long-term protection against rotavirus. The introduction of the rotavirus vaccine is a vital tool in preventing childhood mortality and reducing the burden of rotavirus-related illness.

Importance of Examining Adjacent Joints in Orthopaedic Cases

It is crucial to examine the joints above and below when an orthopaedic problem presents. This principle applies to all age groups, including paediatric cases. For instance, when a child presents with right knee pain, the clinician should also consider hip and ankle pathology.

In cases where the patient has a history of left slipped upper femoral epiphysis (SUFE) and no signs of knee pathology, the clinician should pay particular attention to adjacent joints, especially the hip. According to NICE CKS, urgent assessment is necessary if a child over nine years old experiences painful or restricted hip movements, especially internal rotation, to exclude slipped upper femoral epiphysis. This condition is more common in this age group and requires immediate investigation, including AP and lateral X-rays of the hips.

In summary, examining adjacent joints is crucial in orthopaedic cases, and clinicians should pay attention to any relevant history and symptoms to ensure prompt and accurate diagnosis and treatment.

Understanding the Pneumococcal Vaccine

The pneumococcal vaccine is an important immunization that helps protect against pneumococcal disease, which can cause serious illnesses such as pneumonia, meningitis, and blood infections. However, it’s important to note that there are two types of pneumococcal vaccines – the pneumococcal conjugate vaccine (PCV) and the pneumococcal polysaccharide vaccine (PPV).

The PCV vaccine is given to children under the age of 2, with a booster at 1 year old. On the other hand, the PPV vaccine is given to individuals over the age of 2, particularly those who are 65 years old and above. It’s important to know which vaccine to administer, as the immune response to each vaccine is different.

Aside from the recommended age groups, individuals with certain medical conditions are also eligible for the pneumococcal vaccine. These include those with asplenia or splenic dysfunction, cochlear implants, chronic respiratory or heart disease, chronic neurological conditions, diabetes, chronic kidney disease stage 4/5, chronic liver disease, immunosuppression due to disease or treatment, and complement disorders.

In summary, understanding the pneumococcal vaccine and its different types and recommended age groups is crucial in ensuring proper administration and protection against pneumococcal disease.

Possible causes of microcytic anaemia in a 9-month-old child

Microcytic anaemia is a condition characterized by a low level of haemoglobin (Hb) in red blood cells, along with small cell size. In a 9-month-old child, this can be caused by various factors. One possible cause is overconsumption of cow’s milk, which is low in iron but high in calories. This can lead to a lack of appetite and subsequent deficiencies in vitamins and minerals, especially iron. Another possible cause is folic acid deficiency, which typically results in megaloblastic anaemia rather than microcytic anaemia. Calorie deficit is unlikely in a child with a high weight percentile. Inflammatory bowel disease is rare in infancy and not supported by the given information. Finally, it is worth noting that a normal physiological fall in Hb occurs after birth, but by 6 months of age, the Hb level should be within the range of 110-140 g/l. Treatment for microcytic anaemia may involve dietary education and oral iron supplementation.

Fraser Guidelines and Young People’s Competence to Consent to Contraceptive Advice or Treatment

The Fraser guidelines provide a framework for assessing young people’s competence to consent to contraceptive advice or treatment. According to these guidelines, a young person is considered competent if they understand the doctor’s advice, cannot be persuaded to inform their parents, are likely to start or continue having sexual intercourse with or without contraceptive treatment, are at risk of physical or mental harm without treatment, and require advice or treatment in their best interests without parental consent.

However, there can be considerable differences in the maturity of teenagers seeking contraception, and it is important to consider whether the failure of the consultation is due to the doctor’s communication skills or the young person’s anxiety. For instance, a young person who is not sexually active may not understand the importance of contraception and may need education or counselling to help them make informed decisions about their sexual health.

In such cases, a specialist young people’s service may be able to provide the necessary support, such as counselling, education, or youth work interventions, to help the young person understand the risks and benefits of contraception and make an informed decision about their sexual health. By providing young people with the information and support they need, healthcare professionals can help them make responsible choices about their sexual health and reduce the risk of physical and mental harm.

Hydrocoele in Infants

A hydrocoele is a condition where there is an accumulation of fluid around the testicle within the tunica vaginalis. This condition is common in infants and is usually asymptomatic. The swelling is smooth and fluctuant, and the testis cannot be felt separately. Transillumination is used to confirm the diagnosis.

In most cases, hydrocoeles resolve spontaneously within the first year of life as the processus vaginalis gradually becomes obliterated. Therefore, watchful waiting is usually recommended, and the hydrocoele can be reviewed after the first year of life. However, if the hydrocoele persists, it can be assumed that the processus vaginalis will not close spontaneously, and surgical referral is necessary.

For the treatment of asthma in children, the recommended dose of prednisolone is 1-2 mg/kg once daily for a period of 3-5 days.

The management of acute asthma attacks in children depends on the severity of the attack. Children with severe or life-threatening asthma should be immediately transferred to the hospital. For children with mild to moderate acute asthma, bronchodilator therapy and steroid therapy should be given. The dosage of prednisolone depends on the age of the child. It is important to monitor SpO2, PEF, heart rate, respiratory rate, use of accessory neck muscles, and other clinical features to determine the severity of the attack.

Pulmonary Embolism in Nephrotic Syndrome

Pulmonary embolus is a rare but potentially life-threatening condition that may be missed due to its rarity. However, its presentation in children is similar to that in adults, with symptoms such as hypotension, tachycardia, pleuritic chest pain, and possibly haemoptysis. In children with nephrotic syndrome, the risk of pulmonary embolism is increased due to abnormalities in clotting factors and hypercoagulability. Therefore, it is important for healthcare providers to be aware of this potential complication and consider it in the differential diagnosis of children with nephrotic syndrome presenting with respiratory symptoms. Proper diagnosis and management can prevent serious consequences and improve outcomes for these patients.

Common Causes of Vomiting in Infants: Symptoms and Descriptions

Projectile vomiting is a common symptom in infants, but it can be caused by various conditions. One of the most common causes is infantile hypertrophic pyloric stenosis, which is characterized by forceful vomiting after feeding. This condition is caused by the narrowing of the pyloric canal due to the hypertrophy and hyperplasia of the smooth muscle of the antrum of the stomach and pylorus. It usually occurs in infants aged 2-8 weeks and can be treated by pyloromyotomy.

Gastro-oesophageal reflux is another cause of vomiting in infants, which is characterized by non-forceful regurgitation of milk due to the functional immaturity of the lower oesophageal sphincter. This condition is most common in the first weeks of life and usually resolves by 12-18 months.

Duodenal atresia is a condition that causes hydramnios during pregnancy and intestinal obstruction in the newborn. About 30% of cases have Down syndrome and 30% have cardiovascular abnormalities.

Gastroenteritis is an acute illness that can cause vomiting and loose stools. However, the vomiting is not usually projectile, and the baby would not appear hungry straight after vomiting. These are typical symptoms of pyloric stenosis in this age group.

Lactose intolerance is a condition that develops in people with low lactase levels. Symptoms include bloating, nausea, abdominal pain, diarrhea, and flatulence. Although babies and children can be affected, primary lactose intolerance most commonly appears between 20 and 40 years.

Understanding the Causes of Vomiting in Infants

The NICE paediatric traffic light system identifies a respiratory rate of over 60 per minute as a red flag, regardless of age. Other symptoms that are considered amber or red flags include decreased urine output, dry mucous membranes, and a heart rate of over 150 beats per minute in 12-24-month-olds. A fever of over 39ºC is not an amber or red symptom, but it is considered an amber symptom in 3-6-month-olds and a red flag in children under 3 months.

The NICE Feverish illness in children guidelines were introduced in 2007 and updated in 2013 to provide a ‘traffic light’ system for assessing the risk of febrile illness in children under 5 years old. The guidelines recommend recording the child’s temperature, heart rate, respiratory rate, and capillary refill time, as well as looking for signs of dehydration. Measuring temperature should be done with an electronic thermometer in the axilla for children under 4 weeks or with an electronic/chemical dot thermometer in the axilla or an infra-red tympanic thermometer. The risk stratification table categorizes children as green (low risk), amber (intermediate risk), or red (high risk) based on their symptoms. Management recommendations vary depending on the risk level, with green children managed at home, amber children provided with a safety net or referred to a specialist, and red children urgently referred to a specialist. The guidelines also advise against prescribing oral antibiotics without an apparent source of fever and note that a chest x-ray is not necessary if a child with suspected pneumonia is not being referred to the hospital.

Down’s Syndrome: Epidemiology and Genetics

Down’s syndrome is a genetic disorder that is caused by the presence of an extra copy of chromosome 21. The risk of having a child with Down’s syndrome increases with maternal age, with a 1 in 1,500 chance at age 20 and a 1 in 50 or greater chance at age 45. This can be remembered by dividing the denominator by 3 for every extra 5 years of age starting at 1/1,000 at age 30.

There are three main types of Down’s syndrome: nondisjunction, Robertsonian translocation, and mosaicism. Nondisjunction accounts for 94% of cases and occurs when the chromosomes fail to separate properly during cell division. Robertsonian translocation, which usually involves chromosome 14, accounts for 5% of cases and occurs when a piece of chromosome 21 attaches to another chromosome. Mosaicism, which accounts for 1% of cases, occurs when there are two genetically different populations of cells in the body.

The risk of recurrence for Down’s syndrome varies depending on the type of genetic abnormality. If the trisomy 21 is a result of nondisjunction, the chance of having another child with Down’s syndrome is approximately 1 in 100 if the mother is less than 35 years old. If the trisomy 21 is a result of Robertsonian translocation, the risk is much higher, with a 10-15% chance if the mother is a carrier and a 2.5% chance if the father is a carrier.

Intussusception: A Common Cause of Intestinal Obstruction in Children

Intussusception is a common cause of intestinal obstruction in children aged 5 months to 3 years, accounting for up to 25% of abdominal emergencies in children up to age 5. It occurs when one segment of the bowel invaginates into another just distal to it, leading to obstruction. This condition is more common in boys than girls, with a ratio of approximately 3:2, and two-thirds of patients are under 1-year-old, with the peak age being between 5-10 months.

The clinical features of intussusception include sudden onset of paroxysms of colicky abdominal pain, which may be more insidious in older children. The pain occurs about every 10-20 minutes and is often accompanied by crying. Patients may appear well between paroxysms initially, but early vomiting can rapidly become bile-stained. Neurological symptoms such as lethargy, hypotonia, or sudden alterations of consciousness can also occur.

Other features of intussusception include a palpable ‘sausage-shaped’ mass, often in the right upper quadrant, and absence of bowel in the right lower quadrant (Dance’s sign). Patients may also experience dehydration, pallor, shock, irritability, sweating, and later mucoid and bloody ‘red currant stools’. Late pyrexia may also occur.

In summary, intussusception is a common cause of intestinal obstruction in children, with a range of clinical features that can help diagnose the condition. Early recognition and treatment are essential to prevent complications and improve outcomes.